Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
186.59
+2.44 (1.33%)
Aug 5, 2025, 4:00 PM - Market closed
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $11.30 billion as of August 5, 2025. Its market cap has increased by 43.52% in one year.
Market Cap
11.30B
Enterprise Value
11.65B
1-Year Change
43.52%
Ranking
Category
Stock Price
$186.59
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from $448.80M to $11.30B, an increase of 2,417.57%. That is a compound annual growth rate of 35.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 11.32B | 42.96% |
| Dec 31, 2024 | 7.92B | 9.08% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
| Jan 28, 2015 | 448.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.36B |
| Johnson & Johnson | 411.92B |
| AbbVie | 348.32B |
| AstraZeneca | 229.32B |
| Novartis AG | 226.38B |
| Abbott Laboratories | 226.14B |
| UnitedHealth Group | 218.60B |
| Novo Nordisk | 215.34B |